⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PCRX News
Pacira BioSciences, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach Out
accessnewswire.com
PCRX
Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control
globenewswire.com
PCRX
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect
accessnewswire.com
PCRX
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
globenewswire.com
PCRX
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
globenewswire.com
PCRX
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
globenewswire.com
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PCRX